FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

ICH Carcinogenicity Testing Supplement Out

[ Price : $8.95]

FDA publishes an International Council on Harmonization addendum expanding testing methods for human carcinogenicity risk studies....

Drug Compounding Issues at The Medicine Shoppe

[ Price : $8.95]

FDA warns The Medicine Shoppe in Port Charlotte, FL, that it is producing compounded drugs that dont meet legal requirements and d...

Advisors Considering Data from 2 Maribavir Trials

[ Price : $8.95]

FDA medical reviewers raise issues with two trials of Takedas maribavir to treat cytomegalovirus.

Takeda Pharma Stops 2 TAK-994 Studies

[ Price : $8.95]

Takeda Pharmaceutical Co. stops two Phase 2 studies of TAK-994, an investigational oral orexin agonist for treating narcolepsy, a...

Guide on Animal Drug Adaptive Trials

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance entitled #268 Adaptive and Other Innovative Designs for Effectiveness Stud...

FDA Promotes New Approaches to Animal Drug Approval

[ Price : $8.95]

FDA publishes four final guidances encouraging new sponsors of new animal drugs to pursue innovative ways to prepare and submit da...

Guide on Drug Carcinogenicity Testing

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled S1B(R1) Addendum to S1B Testing for Carcinogenicity of Phar...

Marci Beauty Selling Unapproved Light Therapy Devices: FDA

[ Price : $8.95]

FDA warns Marci Beauty it is marketing seven unapproved light therapy devices.

Class 1 Recall of Medtronic Insulin Pumps

[ Price : $8.95]

FDA classifies as Class 1 a Medtronic recall of certain insulin pumps that was initiated to replace any pump that has a clear reta...

Former FDAer Leading Agilis Consulting

[ Price : $8.95]

Agilis Consulting names former FDA human factors team leader Shannon Hoste as president.